Clinical impact of ATR checkpoint signalling failure in humans

Cell Cycle. 2003 May-Jun;2(3):194-5.

Authors

Mark O'Driscoll¹, Penny A Jeggo

Affiliation

¹ Genome Damage and Stability Centre, University of Sussex, Brighton, East Sussex BN1 9RQ, UK.

PMID: 12734423

No abstract available

Publication types

Review

MeSH terms

Animals
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins*
Cell Transformation, Neoplastic / genetics
Cell Transformation, Neoplastic / metabolism
DNA Damage / genetics*
Eukaryotic Cells / metabolism*
Gene Expression Regulation, Developmental / genetics
Genes, cdc / physiology*
Genetic Predisposition to Disease / genetics
Humans
Nervous System Malformations / genetics
Protein Serine-Threonine Kinases / genetics
Protein Serine-Threonine Kinases / metabolism*

Substances

Cell Cycle Proteins
ATR protein, human
Ataxia Telangiectasia Mutated Proteins
Protein Serine-Threonine Kinases